Accessibility Skip to Global Navigation Skip to Local Navigation Skip to Content Skip to Search Skip to Site Map Menu

Smokefree research

Smoking is the leading cause of preventable morbidity, mortality, and health inequalities in New Zealand, and is estimated to cause 4,500 to 5,000 deaths every year.

Tobacco is a uniquely harmful consumer product responsible for the premature death of half its long-term users. No other legal consumer product causes such widespread harm; smoking harms nearly every organ of the body and is a leading cause of cancer, heart disease, respiratory disease, and a range of other conditions.

The New Zealand Government has commitment to making Aotearoa New Zealand smokefree by the year 2025, which means a reduction in smoking prevalence to less than 5% and a reduction in availability of tobacco to minimal levels. Research has an important role to play in achieving this national goal.

While maintaining a broad interest in all aspects of tobacco control, our research team focuses on reducing the availability of tobacco. Our research includes spatial analyses of the locations of tobacco retailers, and examining policy options for reducing availability. We also undertake research in the area of e-cigarettes and vaping, such as assessing the retail availability and marketing of e-cigarettes and vaping products, and identifying measures to support smokers to transition to exclusive vaping.

Current smokefree projects

  • Geospatial mapping of different tobacco retail reduction policies
  • Exploring small retailers’ claims of reliance on tobacco sales
  • Systematic review on retail access to tobacco and smoking
  • The sale of tobacco in on-license premises
  • Smokefree policies of National Sporting Organisations
  • Electronic cigarettes (Electronic nicotine delivery systems) retailing
  • Geospatial mapping of different tobacco retail reduction policies

Smokefree research team